Gottschalk H, Moricke A, Conter V, Schrappe M, et al. Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009. J Clin Oncol 2025;43:3739-3749.
PMID: 41213101